The following seven NRLs were pinpointed as having a vital prognostic influence on melanoma patients through LASSO regression: EBLN3P, AC093010.2, LINC01871, IRF2-DT, AL162457.2, AC242842.1, and HLA-DQB1-AS1. Here, HLA-DQB1 is linked to melanoma.